TrialThe oncologist2025

A phase II study of trifluridine/tipiracil in combination with ramucirumab in advanced, refractory gastric, or gastroesophageal junction adenocarcinomas.

Dae Won Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.